Credent Connect N Care Secures ₹26.53 Crore from 10 Anchor Investors, Led by Sunil Singhania’s Abakkus Asset Management.

Credent Connect N Care has successfully raised Rs 26.53 crore from 10 anchor investors, indicating robust institutional interest in the company ahead of its initial public offering (IPO), which opened for public subscription on August 13, 2023, and will be available until August 17. The company allotted 14.04 lakh shares to these investors at the upper end of the price band of Rs 189 per share, with prominent names like Abakkus Asset Management, Motilal Oswal, and Hem Growth Opportunities Fund participating in the anchor round. This pre-IPO investment underscores the market’s confidence in Credent’s operational model and growth potential in the healthcare logistics space.

The anchor participation is notably backed by existing significant stakeholders, including Ashish Kacholia and Abakkus, both of whom held their shares prior to the IPO at Rs 187 per share. As per the company’s red herring prospectus, it has built a nationwide healthcare logistics network that collaborates with over 2,500 laboratories, providing essential services like temperature-controlled logistics and last-mile phlebotomy. The financial metrics also demonstrate promising performance, with an anticipated revenue of Rs 214.16 crore for FY2025–26, illustrated by a net profit of Rs 18.45 crore.

For Indian investors, the IPO of Credent Connect N Care is not merely a chance to invest in a company but also an opportunity to tap into the growing intersection of healthcare, logistics, and technology. As the demand for efficient healthcare delivery and diagnostic services increases, the importance of a reliable logistics framework becomes paramount. The successful IPO could pave the way for enhanced valuations and further capital influx for the company, contributing to its ambitious aim to scale revenue to Rs 1,000 crore over the upcoming years. This marks a significant step in India’s evolving healthcare landscape, positioning investors to benefit from Credent’s growth trajectory.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)